Cost analysis of a wait-and-see strategy after radiochemotherapy in distal rectal cancer.
Cihan GaniUlrich GrosseStephan ClasenAndreas KirschniakMartin GoetzClaus RödelDaniel ZipsPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)
A NOM strategy with an intensive surveillance using MRI and rectoscopy will produce costs that are expected to remain below those of immediate surgery.